Sarah Gheuens

CIK 1881190 · Chief Medical Officer · last filed 2026-07-02

Sarah Gheuens is a Chief Medical Officer who has filed 44 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for AGIO, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.05M

Companies

2

Total Filings

44

Lifetime Open-Market Net

-$1.93M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AGIO Chief Medical Officer 84,645 $35.99 $3.05M -$1.93M 27 2026-07-02
VRDN Director $19.51 $0 4 2026-07-02

Recent Filings

44 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 AGIO Mixed +4,368 -$150.5K EDGAR
2026-07-02 VRDN Grant (A) $0 EDGAR
2026-07-01 AGIO Notice (144) −4,007 -$150.5K EDGAR
2026-06-23 AGIO Mixed $0 EDGAR
2026-04-06 AGIO Mixed +5,560 -$102.0K EDGAR
2026-04-02 AGIO Notice (144) −2,940 -$100.5K EDGAR
2026-03-03 AGIO Mixed +9,611 -$117.4K EDGAR
2026-03-02 AGIO Notice (144) −4,055 -$122.6K EDGAR
2026-01-02 AGIO Mixed +3,068 -$79.4K EDGAR
2025-12-30 AGIO Notice (144) −2,932 -$79.6K EDGAR
Showing 110 of 44
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.